Medtronic has obtained the Centers for Medicare & Medicaid Services (CMS) transitional pass-through (TPT) payment for the Symplicity Spyral renal denervation (RDN) catheter. Set to be effective ...
"Very few technologies achieve this qualification, and the core goals of fostering innovation and increasing access mirror Medtronic's desire to continue bringing Symplicity to even more patients ...
"Very few technologies achieve this qualification, and the core goals of fostering innovation and increasing access mirror Medtronic's desire to continue bringing Symplicity to even more patients ...
Approved by the U.S. Food and Drug Administration (FDA) in November 2023, the Medtronic Symplicity Spyral RDN System is a minimally invasive procedure that delivers radiofrequency energy to ...
Both Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation catheters were greenlighted by the FDA in November of last year, following more than a decade of research and ...
With cutting-edge technologies like the Symplicity RDN system, Medtronic’s extensive investment ... of persistent atrial fibrillation and RF ablation of cavotricuspid isthmus-dependent atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback